Studies local return of high grade bone cancer called osteosarcoma
Observes patients with high grade osteosarcoma whose cancer has returned locally.
Plain-language title generated from the registry record
Registry title: An Observational Study of Local Relapse After High Grade Osteosarcoma
Key facts
- Where
- Bologna and Pisa, ItalySee the 2 sites
Where in Italy
- IRCCS Istituto ortopedico RizzoliBologna, ItalyTaking people
- Azienda Ospedaliero Universitaria PisanaPisa, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Istituto Ortopedico Rizzoli
- Trial code
- NCT06017518
- Record updated
- 22 September 2025
- Original description
multicenter retrospective and prospective study in patients with high-grade osteosarcomaRead full original descriptionShow less
An Observational Study of Local Relapse After High Grade Osteosarcoma
multicenter retrospective and prospective study in patients with high-grade osteosarcoma
Inclusion: Patients who experienced LR as first event of recurrence after treatment for localized high-grade osteosarcoma of bone, including cases with synchronous lung metastases; Adequate patient compliance to follow-up visits; Written informed consent prior to any study-specific analysis and/or data collection; No age limits.
Exclusion: Cases of LR demonstrated after > 3 months after metastatic disease; Impossibility to ensure adequate compliance.